Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 2/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | USP2 | O75604 | 1/20 | 0.43 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.43 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.43 |
| ▸ | INPPL1 | O15357 | 1/20 | 0.37 |
| ▸ | INPP5B | P32019 | 1/20 | 0.37 |
| ▸ | INPP5A | Q14642 | 1/20 | 0.37 |
| ▸ | GRM8 | O00222 | 6/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 6/20 | 0.37 |
| ▸ | GRM6 | O15303 | 4/20 | 0.35 |
| ▸ | HPD | P32754 | 4/20 | 0.35 |
| ▸ | KMO | O15229 | 1/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2852379 | 0.78 | GPR35 (0.45) | KDM4EKMOSMN1; SMN2 | |
| SCHEMBL14053131 | 0.72 | INPPL1 (0.49) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL4777066 | 0.72 | INPPL1 (0.49) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| Lysine SCHEMBL10754341 | 0.71 | GRM4 (0.49) | GRM8GRM4GRM6 | |
| SCHEMBL845399 | 0.70 | GPR35 (0.51) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL845400 | 0.70 | GPR35 (0.51) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL2438828 | 0.69 | INPPL1 (0.49) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL12487138 | 0.69 | INPPL1 (0.49) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL2438837 | 0.69 | INPPL1 (0.49) | HPGDALDH1A1KDM4EUSP2PDE3A | |
| SCHEMBL9655977 | 0.67 | KDM4E (0.41) | HPGDALDH1A1KDM4EHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11859232-B2 | Screening for chemotherapy resistance in human haploid cells | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2024-01-02 | — | — | US | disclosed |
| US-20230364062-A1 | METHOD OF TREATING MYELOID MALIGNANCIES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2023-11-16 | — | — | US | disclosed |
| EP-4228637-A1 | METHOD OF TREATING MYELOID MALIGNANCIES | Yeda Research and Development Co. Ltd (IL) | 2023-08-23 | — | — | EP | disclosed |
| WO-2022079719-A1 | METHOD OF TREATING MYELOID MALIGNANCIES | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2022-04-21 | — | — | WO | disclosed |
| US-20210275545-A1 | METHOD OF TREATING CANCER PREFERABLY CHARACTERIZED BY EXPRESSION OF A FUSION PROTEIN COMPRISING A MEMBER OF THE E-TWENTY-SIX FAMILY BY ADMINISTERING AN AGENT THAT INHIBITS THE SYNTHESIS AND/OR ACTIVITY OF CORTISOL | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2021-09-09 | — | — | US | disclosed |
| US-20190226003-A1 | SCREENING FOR CHEMOTHERAPY RESISTANCE IN HUMAN HAPLOID CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-07-25 | — | — | US | disclosed |
| EP-3472342-A1 | SCREENING FOR CHEMOTHERAPY RESISTANCE IN HUMAN HAPLOID CELLS | Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. (IL) | 2019-04-24 | — | — | EP | disclosed |
| WO-2017221225-A9 | SCREENING FOR CHEMOTHERAPY RESISTANCE IN HUMAN HAPLOID CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2019-03-21 | — | — | WO | disclosed |
| WO-2017221225-A1 | SCREENING FOR CHEMOTHERAPY RESISTANCE IN HUMAN HAPLOID CELLS | YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. (IL) | 2017-12-28 | — | — | WO | disclosed |
| WO-2016116935-A1 | USE OF RASA2 AS A PROGNOSTIC AND THERAPEUTIC MARKER FOR MELANOMA | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2016-07-28 | — | — | WO | disclosed |
| US-20050164934-A1 | Novel genes associated with the maintenance of differentiation of smooth muscle cells | Kenji Sobue (JP) | 2005-07-28 | — | — | US | disclosed |
| US-20050069930-A1 | Genes and polypeptides relating to human colon cancers | ONCOTHERAPY SCIENCE, INC. (JP) | 2005-03-31 | — | — | US | disclosed |
| US-20050059631-A1 | OBG3 globular head and uses thereof | GENSET S.A. (FR) | 2005-03-17 | — | — | US | disclosed |
| EP-1513934-A2 | GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS | Oncotherapy Science, Inc. (JP) | 2005-03-16 | — | — | EP | disclosed |
| US-6759192-B1 | FOR DIAGNOSIS AND PROGNOSIS | GENSET S.A. (FR) | 2004-07-06 | — | — | US | disclosed |
| WO-2003106617-A2 | OLIGONUCLEOTIDES ANTIBODIES AND KITS INCLUDING SAME FOR TREATING PROSTATE CANCER AND DETERMINING PREDISPOSITION THERETO | TEL AVIV MEDICAL CENTER RESEARCH DEVELOPMENT FUND (IL) | 2003-12-24 | — | — | WO | disclosed |
| WO-2003104275-A2 | GENES AND POLYPEPTIDES RELATING TO HUMAN COLON CANCERS | ONCOTHERAPY SCIENCE, INC. (JP) | 2003-12-18 | — | — | WO | disclosed |
| US-20030082776-A1 | Novel genes encoding protein kinase/protein phosphatase | CHUGAI SEIYAKU KABUSHIKI KAISHA (JP) | 2003-05-01 | — | — | US | disclosed |
| US-6537751-B1 | Use determining genetic basis for disease states; identification of targets for development of drugs; diagnosis; Alzheimer's Disease | GENSET S.A. (FR) | 2003-03-25 | — | — | US | disclosed |
| US-6531279-B1 | Using nucleic acid from biological sample; can use for diagnosis and prognosis of treatment | GENSET S.A. (FR) | 2003-03-11 | — | — | US | disclosed |